McDermott Will & Schulte advises Owkin on the carve-out of Waiv and its $33 million financing

McDermott Will & Schulte advised Owkin on the carve-out of Waiv (formerly Owkin Dx) and its $33 million financing.

Waiv builds AI solutions in digital pathology to advance precision oncology.

The Series A financing was led by Alpha Intelligence Capital Fund II, OTB Fund 2, Karista, Serena Data Ventures II and SISTAFUND.

McDermott Will & Schulte advised Owkin, alongside Owkin’s in-house legal team that comprised Pierre-Henri Brieau, Anne-Charlotte Paut and Sarah Candelibes- with:

• Emmanuelle Trombe, partner, Sophie Lafay and Lucie Martin, counsel, Natacha Vasak and Camille Pasquereau, associates, on Life Sciences and Corporate aspects
• Romain Desmonts, partner and Fanny Le Pogam, associate, on tax aspects

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.